The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

Breast Cancer Research and Treatment

Volumn 136, Issue 3, 2012, Pages 907-909

  Akbari, Mohammad R ^a,b   Kluźniak, Wojciech ^c   Rodin, Rachelle ^a   Li, Song ^a   Wokołorczyk, Dominika ^c   Royer, Robert ^a   Kashyap, Aniruddh ^c   Menkiszak, Janusz ^c   Lubinski, Jan ^c   Narod, Steven A ^a,b   Cybulski, Cezary ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Breast cancer; HOXB13; p.Gly84Glu

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE DETECTION; HIGH RISK POPULATION; HOXB13 GENE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT; ADOLESCENT; BREAST TUMOR; CANADA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MIDDLE AGED; MUTATION; POLAND; VERY ELDERLY;

HOMEODOMAIN PROTEIN; HOXB13 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANADA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; MUTATION; POLAND; YOUNG ADULT;

EID: 84878760680     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2295-y     Document Type: Article

References (17)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
2. Wooster R, Bignell G, Lancaster J, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
3. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 9:665-676
4. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239-1241
5. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK21100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55-59
6. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165-167
7. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366(2):141-149
8. Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, et al. (2012) Association between germline HOXB13 G84E mutation and risk of prostate cancer. J Natl Cancer Inst 104(16):1260-1262
9. Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR (2012) Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. Cancer Epidemiol Biomarkers Prev 21(8):1348-1353
10. Graham A (1994) Developmental patterning: the Hox code out on a limb. Curr Biol 4:1135-1137
11. Nunes FD, de Almeida FC, Tucci R, de Sousa SC (2003) Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras 17(1):94-98
12. Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L, Cillo C (2003) In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 39(2):257-264
13. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5(6):607-616
14. Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, et al. (2006) The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 24(28):4611-4619
15. Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van Staveren IL, et al. (2007) HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study. J Clin Oncol 25(6):662-668
16. Alanee S, Couch F, Offit K (2012) Association of a HOXB13 variant with breast cancer. N Engl J Med 367(5):480-481
17. Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH (2004) HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res 64:9185-9192